Jen Barnes
Impact in
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Receptor Mechanisms and Signaling 3
- Cancer therapeutics and mechanisms 2
- DNA Repair Mechanisms 2
-
- Neuropeptides and Animal Physiology 4
- Neuroscience and Neuropharmacology Research 4
- Co-authors
- Guy A. Higgins (3 shared papers)Deborah Evans (2 shared papers)D. I. C. SCOPES (2 shared papers)H. Thomas Rupniak (3 shared papers)Richard B. Anderson (2 shared papers)Ann G. Hayes (1 shared paper)Jason Brown (1 shared paper)Paul Beswick (1 shared paper)
- Journals
- British Journal of Pharmacology (3 papers)Neuroscience (2 papers)Cancer Research (2 papers)Molecular Cancer Research (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Jen Barnes
14 papers receiving 469 citations
Peers
Comparison fields: 5 of 73
- Cellular and Molecular Neuroscience 161
- Developmental Neuroscience 30
- Physiology 170
- Neurology 51
- Biological Psychiatry 10
Countries citing papers authored by Jen Barnes
This map shows the geographic impact of Jen Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen Barnes more than expected).
Fields of papers citing papers by Jen Barnes
This network shows the impact of papers produced by Jen Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen Barnes. The network helps show where Jen Barnes may publish in the future.
Co-authors
The 25 scholars most cited alongside Jen Barnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 98 | |
| 2 | 1996 | 88 | |
| 3 | 2003 | 72 | |
| 4 | 1992 | 66 | |
| 5 | 1997 | 52 | |
| 6 | Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function. | 1996 | 46 |
| 7 | 2013 | 18 | |
| 8 | 2017 | 14 | |
| 9 | 1992 | 11 | |
| 10 | 1994 | 11 | |
| 11 | 2012 | 10 | |
| 12 | 1993 | 8 | |
| 13 | 1987 | 5 | |
| 14 | 2000 | 2 | |
| 15 | 2017 | 0 |
About Jen Barnes
Jen Barnes is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Physiology, Oncology and Organic Chemistry, having authored 15 papers that have together received 501 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Receptor Mechanisms and Signaling (3 papers), Alzheimer's disease research and treatments (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer therapeutics and mechanisms (2 papers), DNA Repair Mechanisms (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (161 citations), Developmental Neuroscience (30 citations), Physiology (170 citations), Neurology (51 citations) and Biological Psychiatry (10 citations). Jen Barnes has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Guy A. Higgins, Deborah Evans, D. I. C. SCOPES, H. Thomas Rupniak, Richard B. Anderson, Ann G. Hayes, Jason Brown, Paul Beswick, Jane Clapham and A.D. Michel. Their work appears in journals such as British Journal of Pharmacology, Neuroscience, Cancer Research, Molecular Cancer Research and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.